BSE filing, NSE: POLYMED. Summary written from the filing by ALFA Finder's alert engine.
Poly Medicure Ltd: key numbers
- Share price
- ₹1,469.90
- Market cap
- ₹14,899 Cr
- Revenue (annual)
- ₹1,875 Cr
- Net profit (annual)
- ₹322.1 Cr
- P/E (TTM)
- 47.3×Sector 52.0×
- Promoter holding
- 62.42%+0.00% QoQ
- FII holding
- 5.36%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Poly Medicure Ltd
All →Poly Medicure Other Announcement
The company submitted its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI Regulation 31(1)(b).
Poly Medicure Annual General Meeting
Poly Medicure conducted its 31st Annual General Meeting on September 5, 2026, via video conferencing. This filing provides a summary of the meeting's proceedings and agenda items.
Poly Medicure Annual Report
Poly Medicure has filed its Notice of the 31st Annual General Meeting and the Annual Report for the financial year ended March 31, 2026.
Poly Medicure Dividend
Poly Medicure has announced a record date of August 29, 2026, for a final dividend of ₹3.50 per equity share for FY 2025-26.
Poly Medicure Annual General Meeting
Poly Medicure Limited has scheduled its 31st Annual General Meeting for September 05, 2026, to transact ordinary and special businesses, including dividend declaration.
Poly Medicure Earnings Call Transcript: Key Takeaways
PolyMed Q1FY27 shows strong standalone margin performance beating guidance, but consolidated numbers are dragged by the Middle East crisis and pricing pressure in the renal segment from Chinese dumping.
- Call
- Guides 100% growth
Other board meeting date announcements
All →Vascon Engineers Board Meeting Date
Vascon Engineers has scheduled a board meeting on November 3, 2026 for quarterly results and NCD fund raising. Trading window stays closed until results are declared.
Ruchi Infrastructure Board Meeting Date
Ruchi Infrastructure schedules a board meeting on 4 November 2026 to approve unaudited quarterly and half-year results. Trading window remains closed until 6 November 2026.
Swastika Castal Board Meeting Date
Swastika Castal will hold a board meeting on 4 November 2026 to consider unaudited results for period ended 30 September 2026. Trading window stays closed until results.
GTL Board Meeting Date
GTL Ltd will hold a board meeting on 5 November 2026 to consider unaudited results for quarter ended 30 September 2026. Results are proposed until the meeting.
Acetech E-Commerce Board Meeting Date
Acetech E-Commerce will hold a board meeting on 03-Nov-2026 to consider a fund raise through a rights issue and other business. The trading window stays closed until 48 hours after the outcome is disseminated.
Camlin Fine Sciences Board Meeting Date
Camlin Fine Sciences' board meets on 03 Nov 2026 to consider results and a proposed rights issue. Trading window closes until 05 Nov 2026.